Creating a clot adhesive stentriever to treat acute ischemic stroke (AIS)

The clinical need:

In AIS patients where mechanical thrombectomy (MT) leads to successful reperfusion only one-half have a favorable clinical outcome

Journal of NeuroInterventional Surgery | 2021 | Vol 13:14-18

Complete reperfusion on the first device pass - a major determinant of good outcomes - is achieved today in fewer than 30% of cases

Zaidat et al. | First Pass Effect - A New Measure for Stroke Thrombectomy Devices | Stroke | 2018

Most emboli released during MT are small and may cause vessel obstructions not detectable by angiography and therefore not considered in TIPI ratings

Frontiers in Neurology | May 2020 | Vol. 11 Article 386

There is an unmet need for treatment of occlusions is distal vessel which represent up to 40% of AIS incidents and are caused in part by embolization from thrombectomy procedures in more proximal vessels.

Saver at al., Thrombectomy for Distal, Medium Vessel Occlusions - A Consensus Statement on Present Knowledge and Promising Directions.  Stroke. September 2020;51:2872–2884.

Our evidence:

Promising results for KAPTO coating on stentrievers in cranial flow model

Clot engagement

Better adhesion between clots and coated stentrievers than with bare metal devices

Incidence of clots detaching from stentriever before captured in catheter

Distal embolization

Coated stentrievers better captured emboli released during the retrieval, reducing the number of emboli flushed distally

Amount of particles collected at the
distal end of the cranial model

KAPTO’s technology to target NETs is well-founded in basic science. The coating creates a differentiated stent retriever that actively binds with elements of the embolus to reduce the risk of distal embolization.
— Matthew Gounis, Ph.D., Director, New England Center for Stroke Research, UMass Medical School

Supporting current and emerging stroke treatment

Expanded stentriever practice

Kapto’s coating supports current stentriever applications

  • well-established treatment methods for large vessel occlusions (LVO); and

  • emerging techniques for more distal medium vessel occlusions (MeVO).

Treatment of distal vessel occlusions is the next frontier in endovascular thrombectomy. 
— Saver at al., Thrombectomy for Distal, Medium Vessel Occlusions - A Consensus Statement on Present Knowledge and Promising Directions. Stroke (2020)

Supporting unmet needs for distal vessel occlusion (DVO)

Clot removal from remote, small and fragile vessels requires very low-profile or compressible retrieval devices.

Additional clot engagement provided by the Kapto coating is especially relevant for such devices with very small surface areas.

About 70% of operators felt that appropriate tools to treat MeVO stroke do not exist or that current devices could be improved.
— Kashani et al., Endovascular Device Choice and Tools for Recanalization of Medium Vessel Occlusions: Insights From the MeVO FRONTIERS Int. Survey. Frontiers in Neurology (2021)